Results 21 to 30 of about 1,283,944 (322)

Cost-Effectiveness of Physical Rehabilitation and Care of Older Home-Dwelling Persons after Hip Fracture: A Systematic Review and Narrative Synthesis

open access: yesJournal of Rehabilitation Medicine, 2022
Objective: To provide a systematic review of the literature and knowledge base of cost per quality-adjusted life year of physical rehabilitation and care of older persons after hip fracture.
Jonas Ammundsen Ipsen   +5 more
doaj   +1 more source

The application of the QALY measure in the assessment of the effects of health interventions on an older population: a systematic scoping review

open access: yesArchives of Public Health, 2021
Background One of the most commonly used types of evaluation methods is cost-utility analysis (CUA), using the Quality Adjusted Life Year (QALY) indicator as a preference-based measure for assessing effects of a given programme.
Ewa Kocot   +2 more
doaj   +1 more source

Income-related inequality in life-years and quality-adjusted life-years [PDF]

open access: yesJournal of Health Economics, 2000
We estimate the income-related inequality in Sweden with respect to life-years and quality-adjusted life-years (QALYs). We use a large data set from Sweden with over 40,000 individuals followed up for 10-16 years, to estimate the survival and quality-adjusted survival in different income groups.
Gerdtham, Ulf-G., Johannesson, Magnus
openaire   +4 more sources

Sequencing Systemic Therapy Pathways for Advanced Hepatocellular Carcinoma: A Cost Effectiveness Analysis

open access: yesLiver Cancer, 2020
Introduction: Hepatocellular carcinoma (HCC) is the most common form of liver cancer worldwide and carries a poor prognosis. Historically, sorafenib was the only available systemic treatment for advanced HCC.
Christopher Sherrow   +5 more
doaj   +1 more source

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data. [PDF]

open access: yesValue Health, 2018
Objectives To use real-world data to develop a flexible generic decision model to predict cost, life expectancy, and quality-adjusted life-years (QALYs) for follicular lymphoma (FL) in the general patient population.
Wang HI   +6 more
europepmc   +3 more sources

The effect of surfactant type on characteristics, skin penetration and anti-aging effectiveness of transfersomes containing amniotic mesenchymal stem cells metabolite products in UV-aging induced mice

open access: yesDrug Delivery, 2022
Transfersome has been developed to enhance dermal delivery of amniotic mesenchymal stem cell metabolite products (AMSC-MP). AMSC-MP contains many growth factors for managing skin aging, thus improving the quality of an adjusted life year. This study aims
Andang Miatmoko   +9 more
doaj   +1 more source

Cost-effectiveness of physical fitness training for stroke survivors [PDF]

open access: yes, 2018
Background Physical fitness is impaired after stroke, yet fitness training after stroke reduces disability. Several international guidelines recommend that fitness training be incorporated as part of stroke rehabilitation. However, information about cost-
Clifton, E.   +3 more
core   +3 more sources

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis [PDF]

open access: yes, 2003
OBJECTIVE: To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. DESIGN: Modelling cost effectiveness.
Abrams, K.   +6 more
core   +2 more sources

Methods to Estimate Willingness-to-Pay Per Quality Adjusted Life Year as Cost-Effectiveness Threshold

open access: yesJurnal Manajemen dan Pelayanan Farmasi, 2018
Pharmacoeconomic studies, especially the cost-utility analysis method, require a cost-effectiveness threshold for interpretation of the cost-effectiveness ratios of the study. The cost-effectiveness threshold is determined by each country.
Tri Murti Andayani   +3 more
doaj   +1 more source

El labrador: Año I Número 3 - (14/03/22) [PDF]

open access: yes, 1922
BACKGROUND: Use of everolimus-eluting stents (EES) has proven to be clinically effective and safe in patients with ST-segment elevation myocardial infarction but it remains unclear whether it is cost-effective compared to bare-metal stents (BMS) in the ...
Ademi, Zanfina   +17 more
core   +11 more sources

Home - About - Disclaimer - Privacy